In the News

1855 News Items found
scale
Q&A
Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
More than 30,000 oncology professionals from around the world will gather in Chicago from May 31 to June 4 for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. For more information and to set up interviews, email [email protected]. Follow the meeting live on Twitter using the hashtag #ASCO19 and follow MSK on Twitter at @sloan_kettering.
An illustration of an immune cell killing a cancer cell, and a snake attacking a mouse
Feature
How Do Immune Cells Kill Their Prey?
When an immune cell faces a foe, it has more than chemical weapons at its disposal.
Photo of many different types of pills
Q&A
Learn how MSK’s Antibiotic Management Program is leading the way in ensuring that antibiotics and other antimicrobial drugs are used responsibly.
Maria Jasin, PhD, 2019 Shaw Prize Winner
Maria Jasin, PhD, a molecular biologist at the Sloan Kettering Institute, was named a recipient of the Shaw Prize in Life Science and Medicine. Dr. Jasin was recognized for her contributions to research showing that localized double-strand breaks in DNA stimulate recombination in mammalian cells.
An illustration of a man holding a cell phone
In the News
Do Cell Phones Cause Cancer?
We love our smartphones, but could they be harming our health? An MSK expert weighs in.
Mutlinucleated muscle cells from flies
In the Lab
A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.
Asha blowing bubbles at last treatment
Feature
Meet Anna, who underwent care for breast cancer at Memorial Sloan Kettering and documented the experience in photos.
Memorial Sloan Kettering prostate cancer surgeon James Eastham with colleague.
In the Clinic
Giving a two-drug combination before prostate cancer surgery appears to reduce the chance that some high-risk forms of the disease will come back.
Drawing of one human figure set apart from a group of others.
Finding
MSK researchers learn that some cancers may respond to checkpoint inhibitor drugs because of changes called gene fusions.